An “invaluable” treatment for liver tumours ... known as TheraSphere Y90 Microspheres was among those reviewed by NICE, said: “Targeted, minimally invasive cancer treatment can improve ...

The combination of chemotherapy and radioembolization appeared safe and effective in patients with well-differentiated, liver-dominant, grade 3 NETs.

The interventional oncology market valued at US$ 2.53 Billion in 2023, is forecasted to grow at a robust CAGR of 9.0%, reaching US$ ...